Empagliflozin vs Osimertinib

Empagliflozin vs Osimertinib: Overview

This comparison examines the pharmacological differences between Empagliflozin and Osimertinib.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Osimertinib — C28H33N7O2.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Osimertinib — 499.6050 g/mol.

Type: Empagliflozin — Small molecule; Osimertinib — Small molecule.